Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
PLEASANTON, Calif., May 09, 2017 -- The Cooper Companies, Inc. (NYSE:COO) will present at the Jefferies Healthcare Conference in New York, NY, on June 9, 2017. Daniel G. McBride, Esq, Executive Vice President, Chief Operating Officer & President of CooperVision, Inc., will represent the Company in a presentation scheduled to begin at 10:30 AM ET.
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at http://investor.coopercos.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT: Kim Duncan Vice President, Investor Relations [email protected]
